Trial intelligence / Profile preview

Second discontinuation of dasatinib in chronic myeloid leukemia after prior failed TKI stop

NL-OMON58673Phase 2Recruiting

Sponsor

Region Uppsala

Start

Sep 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1